A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer

Trial Profile

A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jan 2013

At a glance

  • Drugs Alvocidib (Primary) ; Gemcitabine; Irinotecan
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Jan 2008 Status changed from in progress to completed.
    • 20 Jun 2007 Status changed from recruiting to in progress.
    • 19 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top